LSE Equity Snapshot

SAR Weekly Equity Report

Sareum Holdings plc

Interactive chart JSON snapshot
Latest Close 23.00 GBP 12 Jun 2026
1W Return -2.1% latest completed week
4W Return 9.5% short-term follow-through
12W Return 48.4% quarterly tape
Trend Breadth 32.7% 17 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
Company Brief

What the company does

Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also develops SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical stage for cancer and cancer-immunotherapy applications; and SRA737, a clinical-stage oral, selective Chk 1 inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. The company has strategic collaboration …

Snapshot

What the weekly tape is saying

SAR closed the latest completed week at 23.00 GBP. The 4-week return is 9.5% and the 12-week return is 48.4%. Trend Signal is active, Market Dynamics is 1.28. Setup signature: Deep recovery attempt with a 59/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 30.1%
Volume 0.5x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 46 Persistence of active Trend Signal over the last year and current streak.
Momentum 100 Blend of 4-week and 12-week follow-through.
Dynamics 78 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 100 Relative leadership and short-term RS change.
Volume 19 Participation compared with the 13-week volume baseline.
Risk Control 13 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
17.68 GBP
Vs Trend Line
30.1%
Fair Value
33.65 GBP
Vs Fair Value
-31.7%
52W High
29.00 GBP
52W Low
9.50 GBP
Drawdown
-20.7%
Range Position
69.2%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -2.1%
4W 9.5%
12W 48.4%
26W 76.9%
52W 61.4%

Trend read

Active Streak
8 weeks
52W Active Weeks
17
52W Active Breadth
32.7%
Sector Scope
GB Healthcare
Sector Rank
44 of 78
Sector Percentile
44.2%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
1.28
4W MD Change
66.8%
Relative Strength
17.92
4W RS Change
35.5%
Expectation
Negative
Probability
29.31%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
482.4K
13W Average
1.0M
52W Average
1.5M
Vs 13W
0.5x
Vs 52W
0.3x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
10.3%
52W Volatility
12.0%
Upside Weeks
23
Downside Weeks
27
Downside Breadth
51.9%
Avg Gain / Loss
11.4% / -6.5%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
LSE
Country
GB
Sector
Healthcare
Industry
Biotechnology
Currency
GBP
Market Cap
34.6M

Opportunity signals

  • Trend Signal is active with a 8-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 23.00 GBP -2.1% 17.68 GBP 33.65 GBP 1.28 17.92 482.4K On
5 Jun 2026 23.50 GBP -6.0% 17.38 GBP 34.35 GBP 1.35 22.43 1.6M On
29 May 2026 25.00 GBP 22.0% 17.07 GBP 35.07 GBP 1.12 30.61 1.8M On
22 May 2026 20.50 GBP -2.4% 16.69 GBP 35.76 GBP 0.84 7.39 533.1K On
15 May 2026 21.00 GBP 5.0% 16.51 GBP 36.36 GBP 0.77 13.22 1.3M On
8 May 2026 20.00 GBP -1.2% 16.35 GBP 37.03 GBP 0.65 7.68 217.8K On
1 May 2026 20.25 GBP -1.2% 16.20 GBP 37.72 GBP 0.44 7.54 571.8K On
24 Apr 2026 20.50 GBP -2.4% 16.38 GBP 38.50 GBP 0.19 8.68 903.3K On
17 Apr 2026 21.00 GBP 31.2% 16.57 GBP 39.11 GBP 0.03 8.41 2.2M Off
10 Apr 2026 16.00 GBP 3.2% 16.77 GBP 39.63 GBP -0.23 -17.01 1.6M Off
3 Apr 2026 15.50 GBP -3.1% 17.04 GBP 40.15 GBP -0.17 -18.93 581.9K Off
27 Mar 2026 16.00 GBP 3.2% 17.26 GBP 40.71 GBP -0.05 -12.72 1.1M Off
20 Mar 2026 15.50 GBP 3.3% 17.39 GBP 41.17 GBP 0.01 -14.94 640.4K Off
13 Mar 2026 15.00 GBP -3.2% 17.61 GBP 41.66 GBP 0.19 -20.33 1.3M Off